nodes	percent_of_prediction	percent_of_DWPC	metapath
Phosphatidylserine—DGKG—prostate gland—prostate cancer	0.0179	0.0519	CbGeAlD
Phosphatidylserine—SMPD3—prostate gland—prostate cancer	0.0167	0.0486	CbGeAlD
Phosphatidylserine—ATP8A1—prostate gland—prostate cancer	0.0164	0.0477	CbGeAlD
Phosphatidylserine—SMPD4—prostate gland—prostate cancer	0.0153	0.0445	CbGeAlD
Phosphatidylserine—PTDSS2—prostate gland—prostate cancer	0.0124	0.0361	CbGeAlD
Phosphatidylserine—SCARB1—prostate gland—prostate cancer	0.0122	0.0355	CbGeAlD
Phosphatidylserine—DGKD—prostate gland—prostate cancer	0.0115	0.0334	CbGeAlD
Phosphatidylserine—PISD—prostate gland—prostate cancer	0.0113	0.0329	CbGeAlD
Phosphatidylserine—SMPD3—urethra—prostate cancer	0.0112	0.0326	CbGeAlD
Phosphatidylserine—PTDSS1—renal system—prostate cancer	0.0108	0.0313	CbGeAlD
Phosphatidylserine—PTDSS2—seminal vesicle—prostate cancer	0.0105	0.0306	CbGeAlD
Phosphatidylserine—SMPD4—renal system—prostate cancer	0.0104	0.0303	CbGeAlD
Phosphatidylserine—DGKD—seminal vesicle—prostate cancer	0.00974	0.0283	CbGeAlD
Phosphatidylserine—PISD—seminal vesicle—prostate cancer	0.00959	0.0278	CbGeAlD
Phosphatidylserine—SCARB1—epithelium—prostate cancer	0.00897	0.0261	CbGeAlD
Phosphatidylserine—PTDSS2—urethra—prostate cancer	0.00833	0.0242	CbGeAlD
Phosphatidylserine—PTDSS1—bone marrow—prostate cancer	0.00816	0.0237	CbGeAlD
Phosphatidylserine—DGKG—testis—prostate cancer	0.00787	0.0229	CbGeAlD
Phosphatidylserine—PISD—renal system—prostate cancer	0.00773	0.0224	CbGeAlD
Phosphatidylserine—DGKD—urethra—prostate cancer	0.00771	0.0224	CbGeAlD
Phosphatidylserine—PISD—urethra—prostate cancer	0.00759	0.022	CbGeAlD
Phosphatidylserine—SMPD3—testis—prostate cancer	0.00738	0.0214	CbGeAlD
Phosphatidylserine—ATP8A1—testis—prostate cancer	0.00723	0.021	CbGeAlD
Phosphatidylserine—SMPD4—testis—prostate cancer	0.00675	0.0196	CbGeAlD
Phosphatidylserine—PRKCA—prostate gland—prostate cancer	0.00673	0.0196	CbGeAlD
Phosphatidylserine—DGKD—bone marrow—prostate cancer	0.00593	0.0172	CbGeAlD
Phosphatidylserine—PISD—bone marrow—prostate cancer	0.00584	0.017	CbGeAlD
Phosphatidylserine—DGKG—lymph node—prostate cancer	0.00571	0.0166	CbGeAlD
Phosphatidylserine—PTDSS2—testis—prostate cancer	0.00548	0.0159	CbGeAlD
Phosphatidylserine—SCARB1—testis—prostate cancer	0.00538	0.0156	CbGeAlD
Phosphatidylserine—SMPD3—lymph node—prostate cancer	0.00535	0.0155	CbGeAlD
Phosphatidylserine—ATP8A1—lymph node—prostate cancer	0.00524	0.0152	CbGeAlD
Phosphatidylserine—DGKD—testis—prostate cancer	0.00507	0.0147	CbGeAlD
Phosphatidylserine—PISD—testis—prostate cancer	0.00499	0.0145	CbGeAlD
Phosphatidylserine—PRKCA—epithelium—prostate cancer	0.00495	0.0144	CbGeAlD
Phosphatidylserine—SMPD4—lymph node—prostate cancer	0.00489	0.0142	CbGeAlD
Phosphatidylserine—PRKCA—renal system—prostate cancer	0.00459	0.0133	CbGeAlD
Phosphatidylserine—PTDSS2—lymph node—prostate cancer	0.00397	0.0115	CbGeAlD
Phosphatidylserine—SCARB1—lymph node—prostate cancer	0.0039	0.0113	CbGeAlD
Phosphatidylserine—DGKD—lymph node—prostate cancer	0.00368	0.0107	CbGeAlD
Phosphatidylserine—PISD—lymph node—prostate cancer	0.00362	0.0105	CbGeAlD
Phosphatidylserine—PRKCA—testis—prostate cancer	0.00297	0.00861	CbGeAlD
Phosphatidylserine—PRKCA—lymph node—prostate cancer	0.00215	0.00624	CbGeAlD
Phosphatidylserine—SCARB1—Metabolism—PIK3CA—prostate cancer	1.89e-05	2.88e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—NQO1—prostate cancer	1.88e-05	2.87e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—TGFBR2—prostate cancer	1.87e-05	2.85e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Innate Immune System—MDM2—prostate cancer	1.87e-05	2.85e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—IL18—prostate cancer	1.87e-05	2.85e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Hemostasis—IL2—prostate cancer	1.86e-05	2.83e-05	CbGpPWpGaD
Phosphatidylserine—DGKD—Signaling Pathways—TP53—prostate cancer	1.85e-05	2.82e-05	CbGpPWpGaD
Phosphatidylserine—DGKG—Signaling Pathways—TP53—prostate cancer	1.85e-05	2.82e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—TH—prostate cancer	1.85e-05	2.82e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—PTHLH—prostate cancer	1.85e-05	2.82e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—TGFBR1—prostate cancer	1.85e-05	2.82e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Cell Cycle, Mitotic—CDKN1A—prostate cancer	1.85e-05	2.82e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Innate Immune System—ERBB2—prostate cancer	1.84e-05	2.81e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—ITPR1—prostate cancer	1.84e-05	2.81e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—CYP3A4—prostate cancer	1.83e-05	2.79e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Innate Immune System—PIK3CB—prostate cancer	1.82e-05	2.77e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—AKR1C3—prostate cancer	1.82e-05	2.77e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—PDGFRB—prostate cancer	1.81e-05	2.76e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—PRKACB—prostate cancer	1.81e-05	2.76e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—CYP1B1—prostate cancer	1.8e-05	2.75e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Cell Cycle—CDKN1B—prostate cancer	1.79e-05	2.73e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—PPP3CA—prostate cancer	1.76e-05	2.69e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—THBS1—prostate cancer	1.76e-05	2.69e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Cell Cycle, Mitotic—EP300—prostate cancer	1.76e-05	2.68e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—GGT1—prostate cancer	1.74e-05	2.66e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Gene Expression—ERCC2—prostate cancer	1.74e-05	2.66e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—ANXA1—prostate cancer	1.74e-05	2.65e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by NGF—IL6—prostate cancer	1.72e-05	2.63e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—NCOA1—prostate cancer	1.72e-05	2.62e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Gene Expression—NR3C1—prostate cancer	1.71e-05	2.61e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—ERBB3—prostate cancer	1.71e-05	2.61e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—FGFR2—prostate cancer	1.71e-05	2.61e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Cell Cycle—CCND1—prostate cancer	1.71e-05	2.6e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Innate Immune System—CDKN1B—prostate cancer	1.71e-05	2.6e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—PRKCZ—prostate cancer	1.7e-05	2.6e-05	CbGpPWpGaD
Phosphatidylserine—DGKD—Signaling Pathways—IL6—prostate cancer	1.7e-05	2.59e-05	CbGpPWpGaD
Phosphatidylserine—DGKG—Signaling Pathways—IL6—prostate cancer	1.7e-05	2.59e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—CYP19A1—prostate cancer	1.69e-05	2.58e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—LPL—prostate cancer	1.69e-05	2.57e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism of RNA—AKT1—prostate cancer	1.68e-05	2.57e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—PDGFRB—prostate cancer	1.67e-05	2.55e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—GPCR downstream signaling—PIK3CG—prostate cancer	1.67e-05	2.54e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Hemostasis—EP300—prostate cancer	1.67e-05	2.54e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Cell Cycle—CDKN1A—prostate cancer	1.65e-05	2.52e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—FGFR4—prostate cancer	1.65e-05	2.51e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—PARP1—prostate cancer	1.65e-05	2.51e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—RXRA—prostate cancer	1.63e-05	2.49e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—CALCA—prostate cancer	1.63e-05	2.48e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Hemostasis—SRC—prostate cancer	1.62e-05	2.47e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—ERCC2—prostate cancer	1.62e-05	2.47e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Innate Immune System—CTNNB1—prostate cancer	1.61e-05	2.46e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Gene Expression—PPARA—prostate cancer	1.61e-05	2.45e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—CXCL12—prostate cancer	1.59e-05	2.42e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by NGF—AKT1—prostate cancer	1.59e-05	2.42e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—ERBB3—prostate cancer	1.58e-05	2.41e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—FGFR2—prostate cancer	1.58e-05	2.41e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Hemostasis—VEGFA—prostate cancer	1.58e-05	2.41e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Innate Immune System—CDKN1A—prostate cancer	1.58e-05	2.4e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—BCL2L1—prostate cancer	1.58e-05	2.4e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—COMT—prostate cancer	1.57e-05	2.4e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Innate Immune System—PTEN—prostate cancer	1.57e-05	2.4e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Cell Cycle—EP300—prostate cancer	1.57e-05	2.4e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—GSTP1—prostate cancer	1.57e-05	2.39e-05	CbGpPWpGaD
Phosphatidylserine—DGKD—Signaling Pathways—AKT1—prostate cancer	1.56e-05	2.39e-05	CbGpPWpGaD
Phosphatidylserine—DGKG—Signaling Pathways—AKT1—prostate cancer	1.56e-05	2.39e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—ITPR1—prostate cancer	1.54e-05	2.35e-05	CbGpPWpGaD
Phosphatidylserine—SCARB1—Metabolism—AKT1—prostate cancer	1.54e-05	2.35e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Cell Cycle, Mitotic—MYC—prostate cancer	1.53e-05	2.34e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—MTHFR—prostate cancer	1.52e-05	2.32e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—TERT—prostate cancer	1.52e-05	2.31e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by GPCR—PIK3CG—prostate cancer	1.51e-05	2.31e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—TLR4—prostate cancer	1.5e-05	2.29e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Innate Immune System—EP300—prostate cancer	1.5e-05	2.29e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—CASP9—prostate cancer	1.5e-05	2.28e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—GPCR downstream signaling—PIK3CD—prostate cancer	1.47e-05	2.23e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by Wnt—AKT1—prostate cancer	1.46e-05	2.23e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Innate Immune System—SRC—prostate cancer	1.46e-05	2.22e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—TYMS—prostate cancer	1.46e-05	2.22e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Gene Expression—ESR1—prostate cancer	1.45e-05	2.22e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—PRKCQ—prostate cancer	1.45e-05	2.21e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—NGFR—prostate cancer	1.45e-05	2.21e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—HIF1A—prostate cancer	1.45e-05	2.21e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Hemostasis—TGFB1—prostate cancer	1.45e-05	2.21e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—GSTM1—prostate cancer	1.44e-05	2.2e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—ICAM1—prostate cancer	1.44e-05	2.19e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—MAP3K7—prostate cancer	1.43e-05	2.18e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—BAD—prostate cancer	1.43e-05	2.18e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—LPL—prostate cancer	1.41e-05	2.16e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—CAV1—prostate cancer	1.4e-05	2.14e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—FGF10—prostate cancer	1.38e-05	2.1e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Cell Cycle—MYC—prostate cancer	1.37e-05	2.09e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—EGF—prostate cancer	1.37e-05	2.08e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—IRS1—prostate cancer	1.37e-05	2.08e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—CYP1A1—prostate cancer	1.37e-05	2.08e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—ADRB2—prostate cancer	1.36e-05	2.08e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—ERCC2—prostate cancer	1.35e-05	2.06e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—GPCR downstream signaling—JAK2—prostate cancer	1.34e-05	2.05e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Hemostasis—KRAS—prostate cancer	1.34e-05	2.04e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by GPCR—MAP2K1—prostate cancer	1.34e-05	2.04e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by GPCR—PIK3CD—prostate cancer	1.33e-05	2.03e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—VAV3—prostate cancer	1.33e-05	2.03e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—GSK3B—prostate cancer	1.33e-05	2.02e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—BAD—prostate cancer	1.32e-05	2.01e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—TGFBR2—prostate cancer	1.31e-05	2e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—ITPR1—prostate cancer	1.29e-05	1.97e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—CREBBP—prostate cancer	1.28e-05	1.96e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Innate Immune System—EGFR—prostate cancer	1.28e-05	1.95e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—GPCR downstream signaling—PIK3CB—prostate cancer	1.28e-05	1.95e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—APC—prostate cancer	1.28e-05	1.95e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Gene Expression—CREBBP—prostate cancer	1.27e-05	1.94e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—CDH1—prostate cancer	1.27e-05	1.94e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—MTHFR—prostate cancer	1.27e-05	1.94e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—EGF—prostate cancer	1.26e-05	1.92e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—IRS1—prostate cancer	1.26e-05	1.92e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—PPARA—prostate cancer	1.25e-05	1.9e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—IGF1R—prostate cancer	1.23e-05	1.88e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Hemostasis—PIK3CA—prostate cancer	1.23e-05	1.88e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—GPCR downstream signaling—CXCL8—prostate cancer	1.23e-05	1.87e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—GSK3B—prostate cancer	1.23e-05	1.87e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—MAP2K1—prostate cancer	1.22e-05	1.87e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by GPCR—JAK2—prostate cancer	1.22e-05	1.86e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—PIK3CD—prostate cancer	1.22e-05	1.85e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—INS—prostate cancer	1.21e-05	1.84e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Innate Immune System—KRAS—prostate cancer	1.21e-05	1.84e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Gene Expression—SERPINE1—prostate cancer	1.2e-05	1.82e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Hemostasis—TP53—prostate cancer	1.19e-05	1.82e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—CREBBP—prostate cancer	1.18e-05	1.81e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—LPL—prostate cancer	1.18e-05	1.8e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—CAV1—prostate cancer	1.17e-05	1.79e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—GPCR downstream signaling—IL2—prostate cancer	1.17e-05	1.79e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—PDGFRB—prostate cancer	1.17e-05	1.79e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—FGF2—prostate cancer	1.16e-05	1.78e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by GPCR—PIK3CB—prostate cancer	1.16e-05	1.77e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—ITGB3—prostate cancer	1.14e-05	1.74e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—MAP2K1—prostate cancer	1.13e-05	1.72e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Cell Cycle—TP53—prostate cancer	1.12e-05	1.72e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—PIK3CD—prostate cancer	1.12e-05	1.71e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—JAK2—prostate cancer	1.12e-05	1.7e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by GPCR—CXCL8—prostate cancer	1.11e-05	1.7e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—SERPINE1—prostate cancer	1.11e-05	1.69e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Innate Immune System—PIK3CA—prostate cancer	1.11e-05	1.69e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—ERBB3—prostate cancer	1.11e-05	1.69e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—FGFR2—prostate cancer	1.11e-05	1.69e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—BCL2—prostate cancer	1.11e-05	1.69e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—MDM2—prostate cancer	1.09e-05	1.66e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—FGF2—prostate cancer	1.07e-05	1.64e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—ERBB2—prostate cancer	1.07e-05	1.64e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—PIK3CG—prostate cancer	1.07e-05	1.63e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by GPCR—IL2—prostate cancer	1.06e-05	1.62e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—TERT—prostate cancer	1.06e-05	1.62e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—NOS3—prostate cancer	1.06e-05	1.62e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—PIK3CB—prostate cancer	1.06e-05	1.62e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—JAK2—prostate cancer	1.03e-05	1.57e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—HIF1A—prostate cancer	1.01e-05	1.55e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—INS—prostate cancer	1.01e-05	1.54e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Hemostasis—AKT1—prostate cancer	1.01e-05	1.53e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—MDM2—prostate cancer	1.01e-05	1.53e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—CDKN1B—prostate cancer	9.94e-06	1.52e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—CREBBP—prostate cancer	9.91e-06	1.51e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—ERBB2—prostate cancer	9.91e-06	1.51e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—LEP—prostate cancer	9.91e-06	1.51e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Innate Immune System—IL6—prostate cancer	9.82e-06	1.5e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—CAV1—prostate cancer	9.81e-06	1.5e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—PIK3CB—prostate cancer	9.78e-06	1.49e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—IL2—prostate cancer	9.73e-06	1.48e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—KDR—prostate cancer	9.7e-06	1.48e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—PTGS2—prostate cancer	9.69e-06	1.48e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—ESR1—prostate cancer	9.46e-06	1.44e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—PIK3CD—prostate cancer	9.4e-06	1.43e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—CTNNB1—prostate cancer	9.39e-06	1.43e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—BAD—prostate cancer	9.23e-06	1.41e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—CDKN1B—prostate cancer	9.18e-06	1.4e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—CDKN1A—prostate cancer	9.18e-06	1.4e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—PTEN—prostate cancer	9.16e-06	1.4e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Innate Immune System—AKT1—prostate cancer	9.06e-06	1.38e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—APC—prostate cancer	8.94e-06	1.36e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—PIK3CG—prostate cancer	8.94e-06	1.36e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—NOS3—prostate cancer	8.88e-06	1.35e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—IRS1—prostate cancer	8.84e-06	1.35e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—EGF—prostate cancer	8.84e-06	1.35e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—EP300—prostate cancer	8.73e-06	1.33e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—CTNNB1—prostate cancer	8.67e-06	1.32e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—GSK3B—prostate cancer	8.58e-06	1.31e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—SRC—prostate cancer	8.49e-06	1.3e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—CDKN1A—prostate cancer	8.47e-06	1.29e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—INS—prostate cancer	8.46e-06	1.29e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—PTEN—prostate cancer	8.45e-06	1.29e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—CREBBP—prostate cancer	8.29e-06	1.26e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—PIK3CB—prostate cancer	8.19e-06	1.25e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—STAT3—prostate cancer	8.19e-06	1.25e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—IGF1—prostate cancer	8.19e-06	1.25e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by GPCR—EGFR—prostate cancer	8.15e-06	1.24e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—PTGS2—prostate cancer	8.12e-06	1.24e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—EP300—prostate cancer	8.06e-06	1.23e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—MAP2K1—prostate cancer	7.91e-06	1.21e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—PIK3CD—prostate cancer	7.86e-06	1.2e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—SRC—prostate cancer	7.84e-06	1.2e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—GPCR downstream signaling—PIK3CA—prostate cancer	7.78e-06	1.19e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—SERPINE1—prostate cancer	7.77e-06	1.19e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by GPCR—KRAS—prostate cancer	7.69e-06	1.17e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Gene Expression—MYC—prostate cancer	7.57e-06	1.15e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—STAT3—prostate cancer	7.56e-06	1.15e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—FGF2—prostate cancer	7.53e-06	1.15e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—EGFR—prostate cancer	7.44e-06	1.14e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—NOS3—prostate cancer	7.42e-06	1.13e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—JAK2—prostate cancer	7.21e-06	1.1e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—PTEN—prostate cancer	7.08e-06	1.08e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by GPCR—PIK3CA—prostate cancer	7.07e-06	1.08e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—MDM2—prostate cancer	7.04e-06	1.07e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—KRAS—prostate cancer	7.03e-06	1.07e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—MYC—prostate cancer	7.02e-06	1.07e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—TGFB1—prostate cancer	7.01e-06	1.07e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—ERBB2—prostate cancer	6.94e-06	1.06e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—EGFR—prostate cancer	6.87e-06	1.05e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—PIK3CB—prostate cancer	6.85e-06	1.04e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—EP300—prostate cancer	6.75e-06	1.03e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—CXCL8—prostate cancer	6.58e-06	1e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—KRAS—prostate cancer	6.49e-06	9.9e-06	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—PIK3CA—prostate cancer	6.46e-06	9.85e-06	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—CDKN1B—prostate cancer	6.43e-06	9.81e-06	CbGpPWpGaD
Phosphatidylserine—PRKCA—GPCR downstream signaling—AKT1—prostate cancer	6.36e-06	9.7e-06	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—CASP3—prostate cancer	6.3e-06	9.61e-06	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—IL2—prostate cancer	6.29e-06	9.6e-06	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by GPCR—IL6—prostate cancer	6.26e-06	9.55e-06	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—CCND1—prostate cancer	6.13e-06	9.35e-06	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—CTNNB1—prostate cancer	6.07e-06	9.26e-06	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—PIK3CA—prostate cancer	5.96e-06	9.1e-06	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—MMP9—prostate cancer	5.95e-06	9.08e-06	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—CDKN1A—prostate cancer	5.93e-06	9.05e-06	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—PTEN—prostate cancer	5.92e-06	9.03e-06	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by GPCR—AKT1—prostate cancer	5.77e-06	8.81e-06	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—IL6—prostate cancer	5.72e-06	8.72e-06	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—EP300—prostate cancer	5.65e-06	8.61e-06	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—SRC—prostate cancer	5.49e-06	8.37e-06	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—VEGFA—prostate cancer	5.35e-06	8.15e-06	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—STAT3—prostate cancer	5.29e-06	8.07e-06	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—IL6—prostate cancer	5.28e-06	8.05e-06	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—AKT1—prostate cancer	5.28e-06	8.05e-06	CbGpPWpGaD
Phosphatidylserine—PRKCA—Gene Expression—AKT1—prostate cancer	5.25e-06	8e-06	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—PIK3CA—prostate cancer	4.99e-06	7.62e-06	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—MYC—prostate cancer	4.92e-06	7.5e-06	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—TGFB1—prostate cancer	4.91e-06	7.48e-06	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—AKT1—prostate cancer	4.87e-06	7.43e-06	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—EGFR—prostate cancer	4.81e-06	7.34e-06	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—KRAS—prostate cancer	4.55e-06	6.93e-06	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—PIK3CA—prostate cancer	4.18e-06	6.37e-06	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—AKT1—prostate cancer	4.08e-06	6.22e-06	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—TP53—prostate cancer	4.04e-06	6.16e-06	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—IL6—prostate cancer	3.7e-06	5.64e-06	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—AKT1—prostate cancer	3.41e-06	5.2e-06	CbGpPWpGaD
